{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-093268","form_type":"8-K","ticker":"JBIO","cik":"0001798749","company_name":"Jade Biosciences, Inc.","filed_at":"2021-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.719141+00:00","generated_at":"2026-06-30T04:34:09.251612+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Aerovate Therapeutics appoints Allison Dorval to Board of Directors","bullets":["Allison Dorval, CFO of Voyager Therapeutics, appointed to Board effective July 15, 2021.","Dorval appointed chair of Audit Committee; Joshua Resnick resigns from Audit Committee.","Maha Katabi steps down as Audit Committee chair but remains a member; Dorval qualifies as independent and financial expert.","Dorval to serve as Class II director until the 2023 annual meeting of stockholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-093268","json":"https://secwatch.observer/filing/0001104659-21-093268.json","markdown":"https://secwatch.observer/filing/0001104659-21-093268.md","text":"https://secwatch.observer/filing/0001104659-21-093268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/0001104659-21-093268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/tm2122221d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:34:09.251612+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"582a0d039a","claim":"Allison Dorval was appointed as Director at Jade Biosciences, Inc..","evidence_excerpt":"the Board appointed Allison Dorval as a member of the Board, effective as of July 15, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1798749/000110465921093268/0001104659-21-093268-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}